Nuclear translocation of STAT3 and NF-κB are independent of each other but NF-κB supports expression and activation of STAT3
Abstract
NF-κB and STAT3 are essential transcription factors in immunity and act at the interface of the transition from chronic inflammation to cancer. Different functional crosstalks between NF-κB and STAT3 have been recently described arguing for a direct interaction of both proteins. During a systematic analysis of NF-κB/STAT3 crosstalk we observed that appearance of the subcellular distribution of NF-κB and STAT3 in immunofluorescence heavily depends on the fixation procedure. Therefore, we established an optimized fixation protocol for the reliable simultaneous analysis of the subcellular distributions of both transcription factors. Using this protocol we found that cytokine-induced nuclear accumulation of NF-κB or STAT3 did not alter the subcellular distribution of the other transcription factor. Both knockout and overexpression of STAT3 does not have any major effect on canonical TNFα-NF-κB signalling in MEF or HeLa cells. Similarly, knockout of p65 did not alter nuclear accumulation of STAT3 in response to IL-6. However, p65 expression correlates with elevated total cellular levels of STAT3 and STAT1 and supports activation of these transcription factors. Our findings in MEF cells argue against a direct physical interaction of free cellular NF-κB and STAT3 but point to more intricate functional interactions.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The suggested mechanisms for the STAT3-NF-κB crosstalk are often contradictory and a consensus has not been reached.
“Thus, the suggested mechanisms for the STAT3-NF-κB crosstalk are often contradictory and a consensus has not been reached.”
From Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading (2017) · cites this paper as [21]
Some studies suggest cooperation between STAT3 and NF-κB, while others show antagonism.
“Some suggest cooperation between them, while others show antagonism2, 16–21.”
From Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading (2017) · cites this paper as [21]
The crosstalk between STAT3 and NF-κB is an active field of research with studies showing contradictory outcomes of concomitant activation of the two TFs.
“The crosstalk between STAT3 and NF-κB is an active field of research with studies showing contradictory outcomes of concomitant activation of the two TFs.”
From Synergistic gene expression during the acute phase response is characterized by transcription factor assisted loading (2017) · cites this paper as [21]
Cites
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860 · see citing works
Shared Principles in NF-κB Signaling
Hayden, M. S., & Ghosh, S. (2008) · Cell · doi:10.1016/j.cell.2008.01.020 · Cited by 4,814 · see citing works
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383 · see citing works
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · see citing works
Self-citationSTATs: transcriptional control and biological impact
Levy, D. E., & Darnell, J. E. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm909 · Cited by 3,201 · see citing works
Regulation and Function of NF-κB Transcription Factors in the Immune System
Vallabhapurapu, S., & Karin, M. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132641 · Cited by 2,578 · see citing works
Targeted disruption of the mouse <i>Stat3</i> gene leads to early embryonic lethality
Takeda, K., Noguchi, K., Shi, W., Tanaka, T., Matsumoto, M., Yoshida, N., Kishimoto, T., & Akira, S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3801 · Cited by 1,323 · see citing works
Duration of Nuclear NF-κB Action Regulated by Reversible Acetylation
Chen, L., Fischle, W., Verdin, E. M., & Greene, W. C. (2001) · Science · doi:10.1126/science.1062374 · Cited by 1,231 · see citing works
Zhong, H., Voll, R. E., & Ghosh, S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80066-0 · Cited by 1,210 · see citing works
Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160 · see citing works
Levy, D., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 925 · see citing works
Single-cell NF-κB dynamics reveal digital activation and analogue information processing
Tay, S., Hughey, J., Lee, T. K., Lipniacki, T., Quake, S. R., & Covert, M. W. (2010) · Nature · doi:10.1038/nature09145 · Cited by 790 · see citing works
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734 · see citing works
The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer
Naugler, W. E., & Karin, M. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.12.007 · Cited by 730 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500168 · Cited by 616 · see citing works
Yang, J., Liao, X., Agarwal, M. K., Barnes, L., Auron, P. E., & Stark, G. R. (2007) · Genes & Development · doi:10.1101/gad.1553707 · Cited by 611 · see citing works
Takeda, K., Kaisho, T., Yoshida, N., Takeda, J., Kishimoto, T., & Akira, S. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.9.4652 · Cited by 584 · see citing works
Inflammatory cytokines in cancer: tumour necrosis factor and interleukin 6 take the stage
Grivennikov, S. I., & Karin, M. (2011) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2010.140145 · Cited by 560 · see citing works
Immunolabeling artifacts and the need for live-cell imaging
Schnell, U., Dijk, F., Sjollema, K. A., & Giepmans, B. N. G. (2012) · Nature Methods · doi:10.1038/nmeth.1855 · Cited by 506 · see citing works
Nuclear localization of IκBα promotes active transport of NF-κB from the nucleus to the cytoplasm
Arenzana‐Seisdedos, F., Turpin, P., Rodríguez, M. S., Thomas, D., Hay, R. T., Virelizier, J., & Dargemont, C. (1997) · Journal of Cell Science · doi:10.1242/jcs.110.3.369 · Cited by 399 · see citing works
Bollrath, J., & Greten, F. R. (2009) · EMBO Reports · doi:10.1038/embor.2009.243 · Cited by 381 · see citing works
Bode, J. G., Albrecht, U., Häussinger, D., Heinrich, P. C., & Schaper, F. (2012) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2011.09.008 · Cited by 379 · see citing works
Buss, H., Dörrie, A., Schmitz, M. L., Hoffmann, E., Resch, K., & Kracht, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409825200 · Cited by 362 · see citing works
The p65 subunit of NF-kappa B regulates I kappa B by two distinct mechanisms.Preprint
Scott, M. L., Fujita, T., Liou, H., Nolan, G. P., & Baltimore, D. (1993) · Genes & Development · doi:10.1101/gad.7.7a.1266 · Cited by 355 · see citing works
STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-α3
Liu, L., McBride, K. M., & Reich, N. C. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0501643102 · Cited by 348 · see citing works
Alonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.5.1621-1632.2001 · Cited by 329 · see citing works
Haspel, R. L., Salditt‐Georgieff, M., & Darnell, J. E. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb01016.x · Cited by 312 · see citing works
Mutational switch of an IL-6 response to an interferon-γ-like response
Costa‐Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J., Is’harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264 · see citing works
YU, Z., ZHANG, W., & KONE, B. C. (2002) · Biochemical Journal · doi:10.1042/bj20020588 · Cited by 255 · see citing works
NF‐κB: A Multifaceted Transcription Factor Regulated at Several Levels
Schmitz, M. L., Mattioli, I., Buss, H., & Kracht, M. (2004) · ChemBioChem · doi:10.1002/cbic.200400144 · Cited by 244 · see citing works
Acetylation of Stat1 modulates NF-κB activityPreprint
Krämer, O. H., Baus, D., Knauer, S. K., Stein, S., Jäger, E., Stauber, R. H., Grez, M., Pfitzner, E., & Heinzel, T. (2006) · Genes & Development · doi:10.1101/gad.364306 · Cited by 220 · see citing works
Essential role of STAT3 in cytokine‐driven NF‐κB‐mediated serum amyloid A gene expression
Hagihara, K., Nishikawa, T., Sugamata, Y., Song, J., Isobe, T., Taga, T., & Yoshizaki, K. (2005) · Genes to Cells · doi:10.1111/j.1365-2443.2005.00900.x · Cited by 162 · see citing works
Agrawal, A. C., Cha‐Molstad, H., Samols, D. R., & Kushner, I. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01608.x · Cited by 159 · see citing works
Adli, M., & Baldwin, A. S. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m603133200 · Cited by 150 · see citing works
Regulation of Stat3 nuclear export
Bhattacharya, S., & Schindler, C. (2003) · Journal of Clinical Investigation · doi:10.1172/jci15372 · Cited by 146 · see citing works
A Role of STAT3 in Rho GTPase-regulated Cell Migration and Proliferation
Debidda, M., Wang, L., Zang, H., Poli, V., & Zheng, Y. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413187200 · Cited by 145 · see citing works
Disruption of STAT3 signalling promotes KRAS-induced lung tumorigenesis
Grabner, B., Schramek, D., Mueller, K. M., Moll, H. P., Svinka, J., Hoffmann, T., Bauer, E., Blaas, L., Hruschka, N., Zboray, K., et al. (2015) · Nature Communications · doi:10.1038/ncomms7285 · Cited by 143 · see citing works
Real time analysis of STAT3 nucleocytoplasmic shuttling
Pranada, A. L., Metz, S., Herrmann, A., Heinrich, P. C., & Müller-Newen, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312530200 · Cited by 140 · see citing works
Self-citationArcone, R., Pucci, P., Zappacosta, F., Fontaine, V., Malorni, A., Marino, G., & Ciliberto, G. (1991) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1991.tb16048.x · Cited by 136 · see citing works
Moreno, R., Sobotzik, J.-M., Schultz, C., & Schmitz, M. L. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq439 · Cited by 133 · see citing works
Guzzo, C., Mat, N. F. C., & Gee, K. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.112599 · Cited by 132 · see citing works
Repression of gene expression by unphosphorylated NF-κB p65 through epigenetic mechanismsPreprint
Dong, J., Jimi, E., Zhong, H., Hayden, M. S., & Ghosh, S. (2008) · Genes & Development · doi:10.1101/gad.1657408 · Cited by 132 · see citing works
Ray, S., Boldogh, I. R., & Brasier, A. R. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.07.055 · Cited by 129 · see citing works
Negative Regulation of STAT3 Protein-mediated Cellular Respiration by SIRT1 Protein
Bernier, M., Paul, R. K., Martín‐Montalvo, A., Scheibye‐Knudsen, M., Song, S., He, H., Armour, S. M., Hubbard, B. P., Bohr, V. A., Wang, L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.200311 · Cited by 127 · see citing works
Pollice, A. A., McCoy, J. P., Shackney, S. E., Smith, C. A., Agarwal, J., Burnolt, D. R., Janocko, L. E., Hornicek, F. J., Singh, S. G., & Hartsock, R. J. (1992) · Cytometry · doi:10.1002/cyto.990130414 · Cited by 111 · see citing works
Soluble human interleukin-6 receptor. Expression in insect cells, purification and characterization.
Weiergräber, O., Hemmann, U., Küster, A., Müller-Newen, G., Schneider, J., Rose-John, S., Kurschat, P., Brakenhoff, J., Hart, M. H. L., Stabel, S., et al. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.661_b.x · Cited by 101 · see citing works
Self-citationNucleocytoplasmic shuttling of persistently activated STAT3
Herrmann, A., Vogt, M., Mönnigmann, M., Clahsen, T., Sommer, U., Haan, S., Poli, V., Heinrich, P. C., & Müller-Newen, G. (2007) · Journal of Cell Science · doi:10.1242/jcs.03482 · Cited by 94 · see citing works
Self-citationAnrather, J., Racchumi, G., & Iadecola, C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409344200 · Cited by 93 · see citing works
The role of the N-terminal domain in dimerization and nucleocytoplasmic shuttling of latent STAT3
Vogt, M., Domoszlai, T., Kleshchanok, D., Lehmann, S., Schmitt, A., Poli, V., Richtering, W., & Müller-Newen, G. (2011) · Journal of Cell Science · doi:10.1242/jcs.072520 · Cited by 80 · see citing works
Self-citationAlonzi, T., Maritano, D., Gorgoni, B., Rizzuto, G., Libert, C., & Poli, V. (2001) · Molecular and Cellular Biology · Cited by 64 · see citing works
Activation of the NF-κB Pathway by the STAT3 Inhibitor JSI-124 in Human Glioblastoma Cells
McFarland, B. C., Gray, G. K., Nozell, S. E., Hong, S. W., & Benveniste, E. N. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0528 · Cited by 62 · see citing works
Multiple reasons for an inefficient STAT1 response upon IL-6-type cytokine stimulation.
Haan, S., Keller, J., Behrmann, I., Heinrich, P., & Haan, C. (2005) · Cellular Signalling · doi:10.1016/j.cellsig.2005.03.010 · Cited by 60 · see citing works
Kim, H. S., Kim, D. C., Kim, H.-M., Kwon, H., Kwon, S. J., Kang, S., Kim, S. C., & Choi, G.-E. (2015) · Scientific Reports · doi:10.1038/srep13414 · Cited by 56 · see citing works
Dhar, K., Rakesh, K., Pankajakshan, D., & Agrawal, D. K. (2013) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00570.2012 · Cited by 55 · see citing works
Blaecke, A., Delneste, Y., Herbault, N., Jeannin, P., Bonnefoy, J., Beck, A., & Aubry, J. (2002) · Cytometry · doi:10.1002/cyto.10115 · Cited by 51 · see citing works
Suthaus, J., Tillmann, A., Lorenzen, I., Bulanova, E., Rose‐John, S., & Scheller, J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-03-0240 · Cited by 44 · see citing works
The Activity of JAK/STAT and NF-κB in Patients with Rheumatoid Arthritis
Świerkot, J., Nowak, B., Czarny, A., Zaczyńska, E., Sokolik, R., Madej, M., Korman, L., Sebastian, A., Wojtala, P., Lubiński, Ł., et al. (2016) · Advances in Clinical and Experimental Medicine · doi:10.17219/acem/61034 · Cited by 41 · see citing works
Loss of p53 Enhances NF-κB-Dependent Lamellipodia Formation
Guo, A. K., Hou, Y.-Y., Hirata, H., Yamauchi, S., Yip, A. K., Chiam, K., Tanaka, N., Sawada, Y., & Kawauchi, K. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24505 · Cited by 34 · see citing works
Sasaki, C. T., Issaeva, N., & Vageli, D. P. (2015) · Head & Neck · doi:10.1002/hed.24231 · Cited by 32 · see citing works
Kulesza, D. W., Carré, T., Chouaı̈b, S., & Kaminska, B. (2012) · Experimental Cell Research · doi:10.1016/j.yexcr.2012.11.005 · Cited by 31 · see citing works
Shaping alternative NF-κB-dependent gene expression programs: new clues to specificity
Natoli, G., & Santa, F. D. (2006) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401880 · Cited by 30 · see citing works
Smith-Clerc, J., & Hinz, B. (2009) · Methods in molecular biology · doi:10.1007/978-1-60327-345-9_4 · Cited by 29 · see citing works
Zouein, F. A., Duhé, R. J., Arany, I., Shirey, K., Hosler, J. P., Liu, H., Saad, I., Kurdi, M., & Booz, G. W. (2014) · Cytokine · doi:10.1016/j.cyto.2013.12.006 · Cited by 20 · see citing works
Vekemans, K., Rosseel, L., Wisse, E., & Braet, F. (2003) · Micron · doi:10.1016/j.micron.2003.09.001 · Cited by 20 · see citing works
Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking
Martincuks, A., Fahrenkamp, D., Haan, S., Herrmann, A., Küster, A., & Müller‐Newen, G. (2016) · Cellular Signalling · doi:10.1016/j.cellsig.2016.03.011 · Cited by 15 · see citing works
Self-citationToll‐like receptor 4 signaling inhibits malignant pleural effusion by altering Th1/Th17 responses
Xu, Q.-Q., Zhou, Q., Xu, L.-L., Lin, H., Wang, X., Ma, W., Zhai, K., Tong, Z.-H., Su, Y., & Shi, H. (2015) · Cell Biology International · doi:10.1002/cbin.10485 · Cited by 13 · see citing works
Li, M., Zhou, L., & Lam, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135033 · Cited by 12 · see citing works
Ramoino, P., Diaspro, A., Fato, M., & Beltrame, F. (1999) · Cytometry · doi:10.1002/(sici)1097-0320(19990401)35:4 · Cited by 6 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
STAT3 and STAT5 Activation in Solid Cancers
Igelmann, S., Neubauer, H. A., & Ferbeyre, G. (2019) · Cancers · doi:10.3390/cancers11101428 · Cited by 120 · see citing works
Salminen, A., Kaarniranta, K., & Kauppinen, A. (2021) · Inflammation Research · doi:10.1007/s00011-021-01498-3 · Cited by 111 · see citing works
Goldstein, I., Paakinaho, V., Baek, S., Sung, M.-H., & Hager, G. L. (2017) · Nature Communications · doi:10.1038/s41467-017-02055-5 · Cited by 97 · see citing works
The STAT3 Target Gene TNFRSF1A Modulates the NF-κB Pathway in Breast Cancer Cells
Egusquiaguirre, S. P., Yeh, J., Walker, S. R., Liu, S., & Frank, D. A. (2018) · Neoplasia · doi:10.1016/j.neo.2018.03.004 · Cited by 71 · see citing works
Roles of DNA repair enzyme OGG1 in innate immunity and its significance for lung cancer
Vlahopoulos, S., Adamaki, M., Khoury, N., Zoumpourlis, V. C., & Boldogh, I. R. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.09.004 · Cited by 65 · see citing works
A Biodegradable Stent with Surface Functionalization of Combined‐Therapy Drugs for Colorectal Cancer
Xie, X., Zheng, X., Han, Z., Chen, Y., Zheng, Z., Zheng, B., He, X., Wang, Y., Kaplan, D. L., Li, Y., et al. (2018) · Advanced Healthcare Materials · doi:10.1002/adhm.201801213 · Cited by 54 · see citing works
Aliena‐Valero, A., Rius‐Pérez, S., Baixauli-Martín, J., Torregrosa, G., Chamorro, Á., Pérez, S., & Salom, J. B. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-02115-w · Cited by 49 · see citing works
Ruan, Z., Liang, M., Shang, L., Lai, M., Deng, X., & Su, X. (2021) · Pancreatology · doi:10.1016/j.pan.2021.01.023 · Cited by 49 · see citing works
Inflammation and tissue homeostasis: the NF-κB system in physiology and malignant progression
Lambrou, G. Ι., Hatziagapiou, K., & Vlahopoulos, S. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05410-w · Cited by 42 · see citing works
Genetic Signatures From RNA Sequencing of Pediatric Localized Scleroderma Skin
Mirizio, E., Liu, C., Yan, Q., Waltermire, J., Mandel, R., Schollaert, K. L., Konnikova, L., Wang, X., Chen, W., & Torok, K. S. (2021) · Frontiers in Pediatrics · doi:10.3389/fped.2021.669116 · Cited by 35 · see citing works
Smith, E. J., Beaumont, R. E., McClellan, A., Sze, C., Lago, E. P., Hazelgrove, L., Dudhia, J., Smith, R. K. W., & Guest, D. J. (2022) · Cell and Tissue Research · doi:10.1007/s00441-022-03726-6 · Cited by 29 · see citing works
Wang, M.-Q., Liu, F.-L., Yao, Y.-F., Zhang, Q., Lu, Z.-H., Zhang, R.-J., Liu, C.-H., Lin, C.-Z., & Zhu, C.-C. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113816 · Cited by 26 · see citing works
Pan, J., Shi, M., Guo, F., Ma, L., & Fu, P. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119946 · Cited by 25 · see citing works
How Macrophages Become Transcriptionally Dysregulated: A Hidden Impact of Antitumor Therapy
Medvedeva, G. F., Kuzmina, D. O., Nuzhina, J., Shtil, A. A., & Сергеевна, Д. М. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052662 · Cited by 23 · see citing works
CDK5RAP3 is a co-factor for the oncogenic transcription factor STAT3
Egusquiaguirre, S. P., Liu, S., Tošić, I., Jiang, K., Walker, S. R., Nicolais, M., Saw, T. Y., Xiang, M. H., Bartel, K., Nelson, E. A., et al. (2019) · Neoplasia · doi:10.1016/j.neo.2019.10.002 · Cited by 23 · see citing works
Peng, S., Shen, L., Tian, M., Li, H., & Wang, S. (2020) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2020.9566 · Cited by 21 · see citing works
Zhao, J., Xie, X., Di, T., Liu, Y., Qi, C., Chen, Z., Li, P., & Wang, Y. (2021) · International Immunopharmacology · doi:10.1016/j.intimp.2020.107229 · Cited by 21 · see citing works
Nucleocytoplasmic Shuttling of STATs. A Target for Intervention?
Ernst, S., & Müller‐Newen, G. (2019) · Cancers · doi:10.3390/cancers11111815 · Cited by 20 · see citing works
Self-citationZhang, W., Xu, C., Wu, J., Ma, X., Yang, Y., Wu, Y., & Lin, J. (2020) · Chemistry & Biodiversity · doi:10.1002/cbdv.202000810 · Cited by 19 · see citing works
Dynamic chromatin accessibility landscape changes following interleukin-1 stimulation
Barter, M. J., Cheung, K., Falk, J., Panagiotopoulos, A., Cosimini, C., O’Brien, S., Teja-Putri, K., Neill, G. W., Deehan, D. J., & Young, D. A. (2020) · Epigenetics · doi:10.1080/15592294.2020.1789266 · Cited by 16 · see citing works
Li, A., Wu, X., Yang, J., Li, J., Guo, H., Zhang, Y., Jiang, H., & Huo, T. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.114584 · Cited by 13 · see citing works
Gao, L., Sang, J., & Cao, H. (2019) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2019.109366 · Cited by 11 · see citing works
Lallo, S., Hardianti, B., Sartini, S., Ismail, I., Laela, D., & Hayakawa, Y. (2022) · Life · doi:10.3390/life12030337 · Cited by 10 · see citing works
Targeting STAT3 Enzyme for Cancer Treatment
Arun, S., Patel, P. K., Lakshmanan, K., Rajangopal, K., Swaminathan, G., & Byran, G. (2024) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/0113895575254012231024062619 · Cited by 9 · see citing works
Wang, K., Miao, Z., Dong, Y., & Ye, B. (2020) · PubMed Central · doi:10.12122/j.issn.1673-4254.2020.02.10 · Cited by 9 · see citing works
Leong, J., & Husain, M. (2024) · Viruses · doi:10.3390/v17010033 · Cited by 22 · see citing works
Vlahopoulos, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168621 · Cited by 8 · see citing works
Effect of fluticasone propionate on human nasal fibroblasts exposed to urban particulate matter
Kim, J., Choi, H., Oh, J., Kim, Y.-H., Kim, S. W., Kim, S. W., Kim, B. G., Cho, J. H., Lee, J., & Lee, D. C. (2019) · Auris Nasus Larynx · doi:10.1016/j.anl.2019.11.002 · Cited by 8 · see citing works
Awasthi, B. P., Chaudhary, P., Lim, D., Yadav, K., Lee, I., Banskota, S., Chaudhary, C. L., Karmacharya, U., Lee, J., Im, S., et al. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.3c02458 · Cited by 7 · see citing works
Can asymmetric post‐translational modifications regulate the behavior of STAT3 homodimers?
Letra‐Vilela, R., Cardoso, B. M., Silva‐Almeida, C., Rocha, A. M., Murtinheira, F., Branco‐Santos, J., Rodrı́guez, C., Martı́n, V., Santa‐Marta, M., & Herrera, F. (2019) · FASEB BioAdvances · doi:10.1096/fba.2019-00049 · Cited by 6 · see citing works
Fentanyl inhibits cell invasion and migration by modulating NF-κB activation in glioma.
Liu, D., & Xu, S.-Y. (2023) · Brain Research · doi:10.1016/j.brainres.2023.148356 · Cited by 5 · see citing works
Gao, J., Rouzi, M. R. Y., Zhang, H., Cai, X., Xu, B., Lu, J., & Lei, T. (2024) · Acta Diabetologica · doi:10.1007/s00592-023-02228-3 · Cited by 3 · see citing works
Ahmed, S. F., Abd‐Elhamid, T. H., Alamer, S. A., Ismail, M. B., Ali, F. E. M., Hassanein, E. H. M., Althagafy, H. S., & Mahmoud, A. R. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-025-01689-5 · Cited by 2 · see citing works
Kim, J., Kim, H., Lee, S., Yu, Y.-J., Ullah, A., Kim, E. Y., Yoo, H., & Chae, H. (2025) · Biomolecules & Therapeutics · doi:10.4062/biomolther.2025.012 · Cited by 1 · see citing works
Acetylshikonin alleviates pulmonary fibrosis through inhibition of the STAT3 signaling pathway
Qiu, M., Cheng, J., Sun, A., Zhou, Y., Ma, C., Ye, Y., Zhou, X. Y., Xu, Y., Hong, X., Zhao, C., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115811 · Cited by 1 · see citing works
Tang, B., Fang, N., Wang, T., Meng, X., & Su, J. (2026) · Phytotherapy Research · doi:10.1002/ptr.70266 · Cited by 1 · see citing works
Papanikolaou, M. A., Gargalionis, A. N., Adamopoulos, C., & Piperi, C. (2026) · Cancer and Metastasis Reviews · doi:10.1007/s10555-026-10349-8 · Cited by 1 · see citing works
Kim, J., Kim, H., Lee, S., Yu, Y.-J., Ullah, A., Kim, E. Y., Yoo, H., & Chae, H. (2024) · Research Square · doi:10.21203/rs.3.rs-4716221/v1
Arsenic-induced circASXL1 regulates 16HBE cell proliferation through the P65 signaling axis
Yang, X., Tan, J., Zhao, R., Duan, T., Yang, J., Chen, B., Yang, X., Wang, J., Jiang, C., Ni, G., et al. (2025) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2025.118298
Zhang, Y., Nong, S., Deng, S., Su, Q., Lu, J., Fang, D., Qin, S., & Ma, Y. (2026) · Frontiers in Oncology · doi:10.3389/fonc.2026.1781380
Probiotic-derived EPS-ZnO nanoparticles: therapeutic potential in colorectal cancer gene regulation
Afsharipoor, S., Nazari, R., Eghdami, A., Fasihi‐Ramandi, M., & Zolfaghari, M. R. (2026) · Cancer Cell International · doi:10.1186/s12935-026-04247-w
Wang, R., 蒋剑, Li, Z., Liu, T., Wang, Y., Xie, M., & Piatkevich, K. D. (2026) · Science Advances · doi:10.1126/sciadv.aef9406 · Cited by 3 · see citing works
Feng, Y., Liu, D., Gu, C., Zhou, T., Zhang, Z., Bonnet, P., & Meng, X. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119935
Gu, C., Li, L., Gan, Y., Liu, H. X., Wan, Y., Li, D., & Mi, K. (2026) · The FASEB Journal · doi:10.1096/fj.202601172r
- Authors
- Martincuks, A., Andryka, K., Küster, A., Schmitz-Van de Leur, H., Komorowski, M., & Müller-Newen, G.
- Affiliations
- RWTH Aachen University (DE)
- Institute of Fundamental Technological Research (PL)
- Venue
- Cellular Signalling
- Publisher
- Elsevier BV
- Published
- 2017-04
- Volume
- 32
- Pages
- 36-47
- ISSN
- 0898-6568 (ISSN-L)
- OpenAlex
- W2570349166
- Cited by
- 45
- References
- 68
- Citations by year
- 2026: 7 · 2025: 5 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 8 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 1
- FWCI
- 1.47
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Cellular Signalling (publishedVersion)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (submittedVersion)
- Funders
- Studienstiftung des deutschen Volkes (AM, IZKF)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Health Sciences › Medicine › Oncology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- STAT3, NF-κB, nuclear translocation, transcription factor crosstalk, subcellular localization, interleukin-6, NF-κB p65, STAT1, chronic inflammation and cancer
- MeSH terms
- Animals, Cell Nucleus, Gene Expression Regulation, HeLa Cells, Humans, Tumor Necrosis Factor-alpha, NF-kappa B, Protein Transport, STAT1 Transcription Factor, STAT3 Transcription Factor, STAT5 Transcription Factor, Mice, Transcription Factor RelA
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review